Diagnostic performance of serum CK-MB, TNF-α and hs-CRP in children with viral myocarditis

被引:15
作者
Chen, Jia [1 ]
Deng, Yuanying [2 ]
机构
[1] 138 Xintongpo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent S Univ, Dept Pediat, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China
关键词
CK-MB; TNF-alpha; hs-CRP; viral myocarditis; INFLAMMATION;
D O I
10.1515/biol-2019-0005
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: The purpose of this study was to investigate the diagnostic performance of serum CK-MB, TNF-alpha and hs-CRP in children with viral myocarditis (VMC). Methods: Fifty-six children with confirmed diagnosis of VMC were included in this study. Of the included 56 cases, 25 subjects were in acute and other 31 were in the recovery stage. A contemporaneous control group of 22 children were included for comparison. The serum concentration of CK-MB, TNF-alpha and hs-CRP were examined in both VMC and control groups. Results: The serum concentration of CK-MB, TNF-alpha and hs-CRP were 31.77 +/- 9.48 (UL), 143.11 +/- 23.27 (ng/L) and 8.10 +/- 1.94(mg/L) for acute stage VMC; 12.72 +/- 4.99 (UL), 83.15 +/- 13.35 (ng/L) and 4.07 +/- 1.12 (mg/L) for recovery stage VMC; 8.11 +/- 3.20 (UL), 68.27 +/- 12.55 (ng/L) and 2.56 +/- 1.27 (mg/L) for control group respectively; The serum concentration of CK-MB, TNF-alpha and hs-CRP were significantly different between acute stage VMC, recovery stage VMC and control groups (p<0.05); Significant positive correlation between CK-MB and hs-CRP were found in acute stage VMC (r=0.54, p=0.01) and recovery stage VMC (r=0.37, p=0.04). Using serum CK-MB, TNF-alpha and hs-CRP as the reference, the differential diagnosis sensitivity for acute and recovery stage VMC were 87.10 (70.17-96.37)%, 87.10 (70.17-96.37)% and 77.42 (58.90-90.415)%; The specificity were 92.00 (73.97-99.02)%, 96.00 (79.65-99.90)% and 100.00 (86.28-100.00)% respectively. Conclusion: Serum concentration of CK-MB, TNF-alpha and hs-CRP in children with VMC were significant increased especially in acute stage, which can be used as biomarkers for VMC diagnosis.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 19 条
[11]  
Niu L, 2015, EUR REV MED PHARMACO, V19, P2856
[12]   Viral myocarditis-diagnosis, treatment options, and current controversies [J].
Pollack, Ari ;
Kontorovich, Amy R. ;
Fuster, Valentin ;
Dec, G. William .
NATURE REVIEWS CARDIOLOGY, 2015, 12 (11) :670-680
[13]   Intravenous immunoglobulin for presumed viral myocarditis in children and adults [J].
Robinson, J ;
Hartling, L ;
Vandermeer, B ;
Crumley, E ;
Klassen, TP .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[14]   Viral myocarditis [J].
Rose, Noel R. .
CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (04) :383-389
[15]  
Suddaby E C, 1996, Crit Care Nurse, V16, P73
[16]  
Talmon Gil, 2015, Harefuah, V154, P641
[17]  
Uhl TL, 2008, CRIT CARE NURSE, V28, P42
[18]   Analysis of the Indicating Value of Cardiac Troponin I, Tumor Necrosis Factor-α, Interleukin-18, Mir-1 and Mir-146b for Viral Myocarditis among Children [J].
Wang, Dahui ;
Li, Taijun ;
Cui, Hongjie ;
Zhang, Yannming .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 40 (06) :1325-1333
[19]  
Zhang Song, 2002, Zhonghua Bing Li Xue Za Zhi, V31, P250